Theseus Pharmaceuticals Income Statement

Financials in millions GBP. Fiscal year is December - November.

Millions GBP. Fiscal year is Dec - Nov.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021
Selling, General & Admin	0.83	0.9	1.03	0.46
Other Operating Expenses	-0.05	-	-	-
Operating Expenses	0.78	0.9	1.03	0.46
Operating Income	-0.78	-0.9	-1.03	-0.46
Interest Expense	-	-0	-0	-0
Currency Exchange Gain (Loss)	-0	-0	-	-
EBT Excluding Unusual Items	-0.78	-0.91	-1.03	-0.46
Asset Writedown	-	-0.79	-0.2	-
Pretax Income	-0.78	-1.69	-1.23	-0.46
Income Tax Expense	-0.12	-	-	-
Net Income	-0.66	-1.69	-1.23	-0.46
Net Income to Common	-0.66	-1.69	-1.23	-0.46
Shares Outstanding (Basic)	181	134	111	28
Shares Outstanding (Diluted)	181	134	111	28
Shares Change (YoY)	34.62%	20.70%	303.90%	-
EPS (Basic)	-0.00	-0.01	-0.01	-0.02
EPS (Diluted)	-0.00	-0.01	-0.01	-0.02
EBIT	-0.78	-0.9	-1.03	-0.46

Updated Aug 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.